News Stories

FDA Approves Collagen Facial Filler


7/03/08


The FDA has approved a new collagen-based facial filler, Evolence, by the OrthoNeutrogena Aesthetics Group, to treat deep facial folds and wrinkles. Evolence has already been used in Canada, Europe, Israel, and South Korea, since 2004, and will now be launched in the US market.

According to the company, the collagen used in the filler is naturally sourced porcine collagen, which is genetically similar to that found in human skin. It is based on Glymaterix technology, which is cross-linked with collagen using the natural sugar, D-Ribose.

When Evolence is injected into the skin, it maintains and enhances the skin's strength, structure, and structural support so that it is not compromised by the aging process.

[CosmeticsDesign.com, July 1, 2008]




|
|

MEDIA CENTER

Interactive Media
Resources
Classifieds
Calendar
Consumer Resources
Media Kit
Advertiser Index
Editorial Advisory Board
Reprints

ADDITIONAL ONLINE RESOURCES

Allied Healthcare
Medical Education
24X7mag
Chiropractic Products Magazine
Clinical Lab Products (CLP)
Orthodontic Products
The Hearing Industry Resource
HME Today
Rehab Management
Physical Therapy Products
Plastic Surgery Products
Imaging Economics
Medical Imaging
RT Magazine
Sleep Review
SynerMed Communications
IMED Communications
Practice Growth
Practice Builders
powered by:
Copyright © 2008 Ascend Media LLC | Plastic Surgery Products | All Rights Reserved.
Privacy Policy | Terms of Service